Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: M. Frank Greiffenstein who wrote (1576)	3/25/1998 4:32:00 PM
From: Josef Svejk	Read Replies (1) \| Respond to of 5736

Humble question, DocStone, have you had a chance to talk to the folks at William Beaumont Hospital? If not, may I again ask you to do so, and let us know what you find out? Thanks in advance, Svejk (GL-15 applies: digiserve.com ;-)

To: M. Frank Greiffenstein who wrote (1576)	3/25/1998 9:48:00 PM
From: Quad Sevens	Respond to of 5736

<<< a theory can never be proven, you can only fail to refute it. >>> What about that theory? Wade

To: M. Frank Greiffenstein who wrote (1576)	3/25/1998 9:55:00 PM
From: GemSeeker	Read Replies (2) \| Respond to of 5736

Found the following post on Yahoo CCSI thread. It was posted in response to an excellent analysis from Skipard. Anyone on this thread have any actual knowledge of royalty rates in this area? <<<<Someone's model said this: ++++++++++++++++ YEAR 1....Assume a deal is in place giving CCSI a minimum of 25% annually. 1st year market penetration of 10%= $100mm x 25% = $25,000,000 in revenues to CCSI. Assume 80% pre-tax margins= $20,000,000mm/ 8.5mm shares= $2.35 pre-tax, but with a substantial tax loss carry forward a lot of this will be sheltered. Assume a market multiple of 30xp/e=$70 price target on pre-tax numbers. ++++++++++++++++ The problem is the first line. "Assume a deal is in place giving CCSI a minimum of 25% annually." That's an outrageous royalty rate. With CCSI's patent position,something like 0.25% would be more reasonable. Even if CCSI had the patents really covered, a typical royalty rate in the diagnostic business would be more like 2.5%. Note that if you assume a more reasonable (and very generous) royalty rate of 2.5%, the target stock price is more like $7. CCSI is way overpriced. >>>>>